Lunai Bioworks (LNAI) EPS (Basic) (QoQ) (2011 - 2026)
Lunai Bioworks (LNAI) EPS (Basic) (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.04 Bn | 130.19 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.58 Bn | 77.59 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.34 Bn | 1.37 Bn |
| 4 | Moderna | 56.52 Bn | 51.38 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.04 Bn | 36.94 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.67 Bn | 27.36 Bn | 992.69 Mn |
| 7 | Insmed | 27.27 Bn | 26.11 Bn | 358.27 Mn |
| 8 | BioNTech SE | 27.14 Bn | 8.75 Bn | 668.28 Mn |
| 9 | Royalty Pharma | 27.12 Bn | 26.28 Bn | - |
| 10 | Lunai Bioworks | 6.94 Mn | 3.78 Mn | 20,942.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.42% |
| Dec 31, 2025 | 45.63% |
| Sep 30, 2025 | 98.01% |
| Jun 30, 2025 | -2,757.09% |
| Mar 31, 2025 | 6.62% |
| Dec 31, 2024 | 91.59% |
| Sep 30, 2024 | -100.81% |
| Jun 30, 2024 | 64.67% |
| Mar 31, 2024 | -597.34% |
| Dec 31, 2023 | 51.49% |
| Sep 30, 2023 | 65.49% |
| Jun 30, 2023 | -433.20% |
| Mar 31, 2023 | 3.71% |
| Dec 31, 2022 | 42.53% |
| Sep 30, 2022 | 91.87% |
| Jun 30, 2022 | -1,358.16% |
| Mar 31, 2022 | 6.36% |
| Dec 31, 2021 | 36.90% |
| Sep 30, 2021 | 45.84% |
| Jun 30, 2021 | -327.26% |